Guadalupe Garcia-Tsao, MD, is chief of digestive diseases for the VA-CT Healthcare System and director of the Clinical and Translational Core of the Yale Liver Center. She treats patients with liver disease, and has particular expertise in cirrhosis and portal hypertension. She also manages patients with portal hypertension caused by conditions other than cirrhosis.
Dr. Garcia-Tsao has completed many clinical studies that have led to improving the management of patients with complications of cirrhosis and is currently interested in issues regarding the progression (or regression) of cirrhosis.
“Patients with cirrhosis and portal hypertension have inspired my clinical practice and my research,” says Dr. Garcia-Tsao, a professor of medicine (digestive diseases) at Yale School of Medicine. “Cirrhosis is the end-stage of any chronic liver disease, and with advances in science, we have different measures to better treat the complications of cirrhosis. We are currently working at measures to prevent these complications from even occurring or to induce cirrhosis regression.”